litlas
ログインアカウント作成

Anna S. Lok

1984–2025 年に発表

252
論文数
57,838
被引用数
121
h 指数
247
i10 指数

被引用数

Anna S. Lok の年別被引用数1979 年: 被引用 1 件1985 年: 被引用 5 件1986 年: 被引用 8 件1987 年: 被引用 13 件1988 年: 被引用 10 件1989 年: 被引用 9 件1990 年: 被引用 8 件1991 年: 被引用 10 件1992 年: 被引用 7 件1993 年: 被引用 13 件1994 年: 被引用 15 件1995 年: 被引用 21 件1996 年: 被引用 24 件1997 年: 被引用 23 件1998 年: 被引用 24 件1999 年: 被引用 45 件2000 年: 被引用 68 件2001 年: 被引用 81 件2002 年: 被引用 112 件2003 年: 被引用 150 件2004 年: 被引用 169 件2005 年: 被引用 245 件2006 年: 被引用 297 件2007 年: 被引用 361 件2008 年: 被引用 348 件2009 年: 被引用 332 件2010 年: 被引用 351 件2011 年: 被引用 346 件2012 年: 被引用 478 件2013 年: 被引用 430 件2014 年: 被引用 445 件2015 年: 被引用 513 件2016 年: 被引用 387 件2017 年: 被引用 329 件2018 年: 被引用 314 件2019 年: 被引用 1,316 件2020 年: 被引用 1,429 件2021 年: 被引用 1,450 件2022 年: 被引用 1,066 件2023 年: 被引用 872 件2024 年: 被引用 1,578 件2025 年: 被引用 664 件2026 年: 被引用 16 件1980〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,927 件、この内訳の 23.5%中国: 引用元論文 2,145 件、この内訳の 12.8%イギリス: 引用元論文 819 件、この内訳の 4.9%イタリア: 引用元論文 801 件、この内訳の 4.8%ドイツ: 引用元論文 775 件、この内訳の 4.6%フランス: 引用元論文 727 件、この内訳の 4.3%日本: 引用元論文 657 件、この内訳の 3.9%カナダ: 引用元論文 568 件、この内訳の 3.4%台湾: 引用元論文 531 件、この内訳の 3.2%韓国: 引用元論文 505 件、この内訳の 3%スペイン: 引用元論文 467 件、この内訳の 2.8%香港: 引用元論文 426 件、この内訳の 2.6%
0%23.5%その他 26.2%

機関

分野

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology6.7%
  • Immunology and Microbiology1.5%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Health Professions0.4%
  • その他2.1%

トピック

  • Liver Disease Diagnosis and Treatment14.9%
  • Hepatitis B Virus Studies14.8%
  • Hepatitis C virus research14.5%
  • Hepatocellular Carcinoma Treatment and Prognosis5.8%
  • Liver Disease and Transplantation5.7%
  • Hepatitis Viruses Studies and Epidemiology3.5%
  • その他40.8%

共著者

全論文

検索で開く
  1. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance

    著者: Norah A. Terrault, Anna S. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica Hwang, Maureen M. Jonas, Robert S. Brown, Natalie Bzowej, John B. Wong - Clinical Liver Disease 2018 被引用: 4,270

  2. A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C

    著者: Chun‐Tao Wai, Joel K. Greenson, Robert J. Fontana, John D. Kalbfleisch, Jorge A. Marrero, Hari S. Conjeevaram, Anna S. Lok - Hepatology 2003 被引用: 4,363

  3. Hepatitis B

    著者: Wen‐Juei Jeng, George Papatheodoridis, Anna S. Lok - The Lancet 2023 被引用: 540

  4. Hepatitis B virus infection

    著者: C. Trépo, Henry Lik‐Yuen Chan, Anna S. Lok - The Lancet 2014 被引用: 1,617

  5. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?

    著者: Grace Lai‐Hung Wong, Ed Gane, Anna S. Lok - Journal of Hepatology 2022 被引用: 260

  6. A global scientific strategy to cure hepatitis B

    著者: Peter Revill, Francis V. Chisari, Joan M. Block, Maura Dandri, Adam J. Gehring, Haitao Guo, Jianming Hu, Anna Kramvis, Pietro Lampertico, Harry L.A. Janssen, Massimo Levrero, Wenhui Li, T. Jake Liang, Seng Gee Lim, Fengmin Lu, Capucine Pénicaud, John E. Tavis, Robert Thimme, Patrick Arbuthnot, André Boonstra, Kyong‐Mi Chang, Per-Jei Chen, Dieter Glebe, Luca G. Guidotti, Jacques Fellay, Carlo Ferrari, Louis Jansen, Daryl Lau, Anna S. Lok, Mala K. Maini, William Mason, Gail Matthews, Dimitrios Paraskevis, Jörg Petersen, Barbara Rehermann, Eui‐Cheol Shin, Alexander Thompson, Florian van Bömmel, Fusheng Wang, Koichi Watashi, Hung‐Chih Yang, Zhenghong Yuan, Man‐Fung Yuen, Timothy M. Block, Veronica Miller, Ulrike Protzer, Christian Bréchot, Stephen Locarnini, Marion G. Peters, Raymond F. Schinazi, Fabien Zoulim - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 495

  7. The scientific basis of combination therapy for chronic hepatitis B functional cure

    著者: Seng Gee Lim, Thomas F. Baumert, Carolina Boni, Ed Gane, Massimo Levrero, Anna S. Lok, Mala K. Maini, Norah A. Terrault, Fabien Zoulim - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 156

  8. Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    著者: Giovanni Raimondo, Stephen Locarnini, Teresa Pollicino, Massimo Levrero, Fabien Zoulim, Anna S. Lok, Jean‐Pierre Allain, Thomas Berg, Antonio Bertoletti, Maurizia Rossana Brunetto, Raffaele Bruno, Ding‐Shinn Chen, Nicola Coppola, Markus Cornberg, Antonio Craxı̀, Maura Dandri, V. Di Marco, Carlo Ferrari, Giovanni Battista Gaeta, Dieter Glebe, Luca G. Guidotti, Anna Kramvis, Pietro Lampertico, Chengyao Li, Jake T. Liang, Alfredo Marzano, T.I. Michalak, Jean–Michel Pawlotsky, Daniele Prati, Massimo Puoti, Didier Samuel, Vincent Soriano, Giovanni Squadrito, Camille Sureau, Christian Trépo, Man‐Fung Yuen - Journal of Hepatology 2019 被引用: 549

  9. PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis

    著者: Vincent Chen, Antonino Oliveri, Matthew J. Miller, Karn Wijarnpreecha, Xiaomeng Du, Yanhua Chen, Kelly C. Cushing, Anna S. Lok, Elizabeth K. Speliotes - Gastroenterology 2023 被引用: 99

  10. α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    著者: Jorge A. Marrero, Ziding Feng, Yinghui Wang, Mindie H. Nguyen, Alex S. Befeler, Lewis R. Roberts, K. Rajender Reddy, Denise M. Harnois, Josep M. Llovet, Daniel P. Normolle, Jackie Dalhgren, David Chia, Anna S. Lok, Paul D. Wagner, Sudhir Srivastava, Myron Schwartz - Gastroenterology 2009 被引用: 756

  11. Use of Liver Imaging and Biopsy in Clinical Practice

    著者: Elliot B. Tapper, Anna S. Lok - New England Journal of Medicine 2017 被引用: 433

  12. Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma

    著者: Emily Harding‐Theobald, Jeremy Louissaint, Bharat Maraj, Edward Cuaresma, Whitney Townsend, Mishal Mendiratta‐Lala, Amit G. Singal, Grace L. Su, Anna S. Lok, Neehar D. Parikh - Alimentary Pharmacology & Therapeutics 2021 被引用: 140

  13. Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion

    著者: George Papatheodoridis, Vasileios Lekakis, Theodoros Voulgaris, Pietro Lampertico, Thomas Berg, Henry Lik‐Yuen Chan, Jia‐Horng Kao, Norah A. Terrault, Anna S. Lok, K. Rajender Reddy - Journal of Hepatology 2022 被引用: 112

  14. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis

    著者: Anna S. Lok, Brian J. McMahon, Robert S. Brown, John B. Wong, Ahmed T. Ahmed, Wigdan Farah, Jehad Almasri, Fares Alahdab, Khalid Benkhadra, Mohamed A. Mouchli, Siddharth Singh, Essa A. Mohamed, Abd Moain Abu Dabrh, Larry J. Prokop, Zhen Wang, M. Hassan Murad, Khaled Mohammed - Hepatology 2015 被引用: 544

  15. Hepatitis D

    著者: Francesco Negro, Anna S. Lok - JAMA 2023 被引用: 106

  16. International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

    著者: Amit G. Singal, Yujin Hoshida, David J. Pinato, Jorge A. Marrero, Jean‐Charles Nault, Valérie Paradis, Nabihah Tayob, Morris Sherman, Young‐Suk Lim, Ziding Feng, Anna S. Lok, Jo Ann Rinaudo, Sudhir Srivastava, Josep M. Llovet, Augusto Villanueva - Gastroenterology 2021 被引用: 158

  17. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis

    著者: Yee Hui Yeo, Hsiu J. Ho, Hwai‐I Yang, Tai‐Chung Tseng, Tetsuya Hosaka, Huy N. Trinh, Min‐Sun Kwak, Young Min Park, James Yan Yue Fung, Marı́a Buti, Manuel Rodríguez, Sombat Treeprasertsuk, Carmen Monica Preda, Teerapat Ungtrakul, Phunchai Charatcharoenwitthaya, Xiangyong Li, Jiayi Li, Jian Zhang, Michael H. Le, Bin Wei, Biyao Zou, An K. Le, Donghak Jeong, Nicholas Chien, Leslie Y. Kam, Chiao‐Chin Lee, Mar Riveiro‐Barciela, Doina Istrătescu, Tassanee Sriprayoon, Yutian Chong, Tawesak Tanwandee, Mariko Kobayashi, Fumitaka Suzuki, Man‐Fung Yuen, Hyo-Suk Lee, Jia‐Horng Kao, Anna S. Lok, Chun‐Ying Wu, Mindie H. Nguyen - Gastroenterology 2018 被引用: 265

  18. Progress towards elimination goals for viral hepatitis

    著者: Andrea L. Cox, Manal H. El‐Sayed, Jia‐Horng Kao, Jeffrey V. Lazarus, Maud Lemoine, Anna S. Lok, Fabien Zoulim - Nature Reviews Gastroenterology & Hepatology 2020 被引用: 204

  19. Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular Carcinoma

    著者: Amit G. Singal, Ashin Mukherjee, Joseph Elmunzer, Peter Higgins, Anna S. Lok, Ji Zhu, Jorge A. Marrero, Akbar K. Waljee - The American Journal of Gastroenterology 2013 被引用: 317

  20. Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol‐Associated Cirrhosis

    著者: Jessica L. Mellinger, Anne C. Fernandez, Kerby Shedden, Gerald Scott Winder, Robert J. Fontana, Michael L. Volk, Frederic C. Blow, Anna S. Lok - Alcoholism Clinical and Experimental Research 2019 被引用: 115

  21. Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort

    著者: Miguel Malespin, A. Sidney Barritt, Stephanie Watkins, Cheryl Schoen, Monica A. Tincopa, Karen D. Corbin, Andrea R. Mospan, Breda Muñoz, Huy N. Trinh, Laurence Weiss, K. Rajender Reddy, Rohit Loomba, Nyingi Kemmer, Anna S. Lok - Clinical Gastroenterology and Hepatology 2021 被引用: 68

  22. Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities

    著者: Karn Wijarnpreecha, Fang Li, Sori Kim Lundin, Deepika Suresh, Michael Song, Cui Tao, Vincent Chen, Anna S. Lok - Alimentary Pharmacology & Therapeutics 2023 被引用: 55

  23. Biomarkers for the Early Detection of Hepatocellular Carcinoma

    著者: Neehar D. Parikh, Anand S. Mehta, Amit G. Singal, Timothy M. Block, Jorge A. Marrero, Anna S. Lok - Cancer Epidemiology Biomarkers & Prevention 2020 被引用: 139

  24. Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda

    著者: Amit G. Singal, Anna S. Lok, Ziding Feng, Fasiha Kanwal, Neehar D. Parikh - Clinical Gastroenterology and Hepatology 2020 被引用: 103